The tariff classification of Erlotinib Tablets and Lamotrigine Extended-Release Tablets in dosage form, from India
Reasoning
The tariff classification of Erlotinib Tablets and Lamotrigine Extended-Release Tablets in dosage form, from India
Cite this ruling
CBP Ruling N309743 (3004909230): The tariff classification of Erlotinib Tablets and Lamotrigine Extended-Release Tablets in dosage form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Pain Relief Cream from Canada
The tariff classification of Mentholatum® Aromatic Nasal Inhaler from China
The tariff classification of acetaminophen tablets and caplets from China
The tariff classification of children’s aspirin tablets, enteric-coated aspirin tablets, and calcium carbonate antacid tablets from China
The tariff classification of children’s aspirin tablets, enteric-coated aspirin tablets, and calcium carbonate antacid tablets from China